Novo Nordisk UK prepared for
all Brexit outcomes
Gatwick, 13 September 2019 – As the biggest insulin supplier in the UK and with 95 years of innovation in diabetes care, Novo Nordisk is committed to ensuring patients’ medicine supplies are unaffected whatever the outcome of Brexit.
Greater Manchester becomes the second city in the UK to join Cities Changing Diabetes, a global intiative to fight the urban diabetes epidemic
Gatwick, 17 June 2019 – Novo Nordisk today announced Greater Manchester as the 22nd city, and second in the UK, to join Cities Changing Diabetes, a global partnership programme designed to address the urban diabetes challenge.
Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact
Bagsværd, Denmark, 30 April 2019 – Novo Nordisk today announced that it will achieve its target to use only renewable electricity in its global production facilities by 2020.
Celebrities join UK leading experts to challenge current perceptions of Type 1 diabetes
London, 30 March 2019 - Today, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
This page is intended for UK consumer media, UK trade/medical media and members of the UK public
UK19NNG00001 April 2019